← FDA WARNING LETTERS
FDA WARNING LETTEROctober 13, 2026
Lovelace Biomedical Research Institute — FDA Warning Letter
Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies
What this record is not
Warning-letter details are published by the U.S. FDA; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative text is on fda.gov.
Company
Lovelace Biomedical Research Institute
Letter date
October 13, 2026
Issuing office
Center for Drug Evaluation and Research (CDER)
READ THE FULL LETTER
The complete warning letter, including every cited observation, is published by the FDA. SPEQ surfaces and indexes it for reference — the authoritative text lives on fda.gov.
View on fda.gov →